The clinical analysis showed that the expression of VEGFA levels were significantly increased in patients with T4 or N1 stage of ESCC compared with those in T2/T3 or N0 stage of ESCC, respectively (Figure S1C,F). The gene discussed is VEGFA; the disease is esophageal squamous cell carcinoma.